SEC Comment Letter 0000000000-22-013305 to NAVA HEALTH MD, LLC (CIK 0001932231)
NAVA HEALTH MD, LLC (CIK 0001932231)
Date: Dec. 9, 2022 · CIK: 0001932231 · Accession: 0000000000-22-013305
AI Filing Summary & Sentiment
File numbers found in text: 333-268022
Show Raw Text
United States securities and exchange commission logo
December 9, 2022
Bernaldo Dancel
Chief Executive Officer
NAVA HEALTH MD, LLC
9755 Patuxent Woods Drive, Suite 100
Columbia, Maryland 21046
Re:NAVA HEALTH MD, LLC
Amendment No. 1 to Registration Statement on Form S-1
Filed December 5, 2022
File No. 333-268022
Dear Bernaldo Dancel:
We have reviewed your amended registration statement and have the following
comments. In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments. Unless we note
otherwise, our references to prior comments are to comments in our November 4, 2022 letter.
Amendment No. 1 to Registration Statement on Form S-1, Filed December 5, 2022
Cover page
1.Please clearly disclose whether your offering is contingent upon final approval of your
NASDAQ listing on your cover page. Please ensure the disclosure is consistent with your
underwriting agreement.
Exhibits
2.Please obtain an updated consent from your auditors, and include it with an amendment to
your filing.
3.We note that you intend to amend and restate your Articles of Incorporation and Bylaws
FirstName LastNameBernaldo Dancel
Comapany NameNAVA HEALTH MD, LLC
December 9, 2022 Page 2
FirstName LastName
Bernaldo Dancel
NAVA HEALTH MD, LLC
December 9, 2022
Page 2
prior to the completion of this offering. Please file your amended and restated Articles of
Incorporation and Bylaws as exhibits.
You may contact Tracie Mariner at 202-551-3744 or Al Pavot at 202-551-3738 if you
have questions regarding comments on the financial statements and related matters. Please
contact Margaret Schwartz at 202-551-7153 or Laura Crotty at 202-551-7614 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Rachel M. Jones, Esq.